MS Patients Seen to Safely Switch to Oral Drugs from Injectable Oral Therapies
Stable multiple sclerosis (MS) patients do not appear to be at any increased risk of disease reactivation while switching to oral…
Articles by Patricia Silva, PhD
National Multiple Sclerosis Society Receives $20,000 From VWR Foundation
The VWR Charitable Foundation recently celebrated its sales teams’ accomplishments by making charitable contributions totaling $100,000 in their honor to five organizations, including…
MS Society Raised $25M to Fund New Research Through NOW Campaign
The National Multiple Sclerosis Society announced that its five-year campaign to raise $250 million has concluded with its goal fully achieved,…
RRMS Drug Works by Shifting Anti-Inflammatory Immune Profile, Study Shows
Researchers have found that changes in the composition of immune molecules — specifically, a shift to more anti-inflammatory cytokines and regulatory…
MS Study into Genetic Origins of Disease Seeks African-American Participants
Researchers at the University of California, San Francisco, (UCSF) are asking African-Americans with multiple sclerosis, as well as family members, to participate in new…
Protein Seen to Impede Remyelination in Multiple Sclerosis Patients
Researchers from Karolinska Institute, Sweden, reported that the immune-associated protein lipocalin-2 (LCN2) is increased in multiple sclerosis, particularly in patients…
MS Trigger Believed to Lie in Microglial Cells, Scientists Report
Researchers have isolated the particular cell types likely to initiate common brain disorders and diseases, such as multiple sclerosis (MS) and…
MS-related Nerve Damage May Be Treatable with Anti-Seizure Drug
Researchers from the University College London (UCL) found that the anti-convulsant drug phenytoin protected neural tissue in patients with optic…
Guidelines Issued for Monitoring of MS Patients on Natalizumab Treatment
A panel of neurologists from the U.K. and Ireland recently developed practical consensus guidelines for monitoring multiple sclerosis (MS) patients…
MS Researchers ID Protein That Works to Block Nervous System Remyelination
A study from the University of Cambridge showed that the membrane-bound signaling protein EphrinB3, which acts by inhibiting the…
Tecfidera Seen to Alter Anti-Inflammatory Profile in Immune Cells
Delayed-release dimethyl fumarate (Tecfidera) was recently approved for patients with relapsing-remitting multiple sclerosis (RRMS), although the mechanisms by which the…
National MS Society Awards Grant to London Researchers
The National Multiple Sclerosis Society in the U.S. has awarded a new grant to a University College London (UCL) research…
Amarantus Subsidiary Merging into Avant Diagnostics to Streamline Assets
Amarantus Bioscience Holdings, Inc., and Avant Diagnostics recently announced they have entered into a Letter of Intent (LOI)…
MS Society to Benefit from Auction of Jay Leno’s Custom Ford Truck
Barrett-Jackson, an Arizona-based auction company specializing in the auction of antique and classic automobiles, has announced that the National Multiple…
EMD Serono Gains Exclusive US Rights to MS Drug for Relapsing Forms of Disease
EMD Serono, the North American biopharmaceutical business arm of Merck, announced it has gained exclusive rights over Rebif (interferon beta-1a)…
MS Treatment that Reboots Immune System Featured on BBC Panorama
A recent BBC Panorama program titled “Can you stop my Multiple Sclerosis?” featured a ground-breaking treatment for select patients with multiple sclerosis (MS)…
MS Clinicians Largely Favor Use of eHealth Technology in Patient Care
A study from the University of Technology Dresden, in Germany, reported on attitudes toward the adoption of electronic health (eHealth)…
MS Resistance Traced to a Gene Variant in Colombia
A Colombian study reported finding an increased risk of multiple sclerosis (MS) associated with a particular allele, or gene variant, in…
Potential MS Stem Cell Therapy Moves into Phase 2 Trial for 1st Time in US
The Tisch MS Research Center of New York (Tisch MSRCNY) recently announced that its stem cell-based therapy as a…
MS Researcher Using £50,000 Donation to Further Research
Dr. Richard Reynolds of Imperial College London spoke of the importance of philanthropy to research during a December 2015 visit from Nigel Furmston, a…
Neuronal Repair in MS May Be Triggered by an Inflammatory Molecule
A new study from The Weizmann Institute of Science, Israel, found that the inflammatory molecule CXCL12 promotes neuronal repair during spontaneous…
Potential MS Treatment Targeting CD3 Receptor Moving into Development
Tiziana Life Sciences, plc, a biotechnology company specializing in drugs to treat immunological and oncological diseases, recently announced its intent to further…
Simple MS Blood Test Said to Be Able to Diagnose Disease at Symptom Onset
IQuity Labs, which specializes in diagnostic tests for autoimmune and other diseases, recently announced that it has received $2 million…
Young MS Patients Gain in Functional Connectivity with Onset of Damage to Brain
A Canadian study showed that child-onset multiple sclerosis (MS) is characterized by increased functional connectivity within the brain, most likely a…
MS Researchers Share Findings on Fall Risk and Balance Improvement
The 5th International Symposium on Gait and Balance in MS, held in September 2015, focused entirely on research into balance…
MS Researcher to Be Honored by International Neuropsychological Society
Ralph H. Benedict, PhD, professor of neurology at the Jacobs School of Medicine and Biomedical Sciences at the University…
MS Patients and Caregivers Invited to Take Part in Meditation Study
A new randomized and controlled trial is recruiting multiple sclerosis (MS) patients to investigate the effect of a mindfulness-based telemedicine intervention program…
MS Drug Under Study No Longer Being Given in Higher Doses to Patients
Teva Pharmaceutical Industries Ltd. and Active Biotech have discontinued the use of higher doses of the drug laquinimod…
Entropy in MS Patients’ Brains Seen to Mirror Level of Disability
A recent study published in the journal PLOS ONE described a new technique with the potential to spot brain…
Multiple Sclerosis Association of America Appoints New President and CEO
The Multiple Sclerosis Association of America (MSAA), a national nonprofit organization and leading resource for the multiple sclerosis (MS)…